Back
Achieve Life Sciences Vs. Perspective Therapeutics Industry Stock Comparison
Buy
52
ACHV
Achieve Life Sciences
Last Price:
4.72
Seasonality Move:
5.03%
Buy
74
CATX
Perspective Therapeutics
Last Price:
1.75
Seasonality Move:
3.58%
Buy
52
Achieve Life Sciences (ACHV)
is a Buy
Is Achieve Life Sciences a Buy, Sell or Hold?
- The current Achieve Life Sciences [ACHV] share price is $4.75. The Score for ACHV is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
- ACHV is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
74
Perspective Therapeutics (CATX)
is a Buy
Is Perspective Therapeutics a Buy, Sell or Hold?
- The current Perspective Therapeutics [CATX] share price is $1.84. The Score for CATX is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
- CATX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ACHV Stock Price Chart
What is Achieve Life Sciences's stock price today?
-
The Achieve Life Sciences share price today is $4.75
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ACHV is experiencing buying pressure, which is a positive indicator for future bullish movement.
CATX Stock Price Chart
What is Perspective Therapeutics's stock price today?
-
The Perspective Therapeutics share price today is $1.84
The current trend is moderately bullish and CATX is experiencing slight selling pressure.
ACHV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.05 | Buy |
| Relative Strength Index (14 RSI): | 58.59 | Buy |
| Chaikin Money Flow: | 80352 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.39 - 4.63) | Buy |
| Bollinger Bands (100): | (3.98 - 4.74) | Buy |
CATX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.13 | Buy |
| Relative Strength Index (14 RSI): | 72.79 | Buy |
| Chaikin Money Flow: | -1301518 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.45 - 1.71) | Buy |
| Bollinger Bands (100): | (0.54 - 1.42) | Buy |
ACHV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.61 | Buy |
| 20-day SMA: | 4.52 | Buy |
| 50-day SMA: | 4.5 | Buy |
| 200-day SMA: | 4.56 | Buy |
| 8-day EMA: | 4.63 | Buy |
| 20-day EMA: | 4.56 | Buy |
| 50-day EMA: | 4.51 | Buy |
| 200-day EMA: | 4.65 | Buy |
CATX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.73 | Buy |
| 20-day SMA: | 1.61 | Buy |
| 50-day SMA: | 1.35 | Buy |
| 200-day SMA: | 0.66 | Buy |
| 8-day EMA: | 1.75 | Buy |
| 20-day EMA: | 1.62 | Buy |
| 50-day EMA: | 1.38 | Buy |
| 200-day EMA: | 0.84 | Buy |
Achieve Life Sciences Earnings Growth & ACHV Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.02 per share, an increase this year of $0.49 per share, and an increase next year of $0.10 per share.
Perspective Therapeutics Earnings Growth & CATX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Achieve Life Sciences Technical Analysis
| Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Perspective Therapeutics Technical Analysis
| Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||